Literature DB >> 32819896

COVID-19-Associated Carotid Atherothrombosis and Stroke.

C Esenwa1, N T Cheng2, E Lipsitz3, K Hsu4, R Zampolin4, A Gersten5, D Antoniello2, A Soetanto2, K Kirchoff2, A Liberman2, P Mabie2, T Nisar2, D Rahimian2, A Brook4, S-K Lee4, N Haranhalli6, D Altschul6, D Labovitz2.   

Abstract

We present a radiology-pathology case series of 3 patients with coronavirus disease 2019 (COVID-19) with acute ischemic stroke due to fulminant carotid thrombosis overlying mild atherosclerotic plaque and propose a novel stroke mechanism: COVID-associated carotid atherothrombosis.
© 2020 by American Journal of Neuroradiology.

Entities:  

Mesh：

Year:  2020        PMID： 32819896      PMCID： PMC7658853          DOI： 10.3174/ajnr.A6752

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


  15 in total

1.  Thromboinflammation and the hypercoagulability of COVID-19.

Authors:  Jean M Connors; Jerrold H Levy
Journal:  J Thromb Haemost       Date:  2020-05-26       Impact factor: 5.824

2.  Stroke and mechanical thrombectomy in patients with COVID-19: technical observations and patient characteristics.

Authors:  Arthur Wang; Grace K Mandigo; Peter D Yim; Philip M Meyers; Sean D Lavine
Journal:  J Neurointerv Surg       Date:  2020-05-25       Impact factor: 5.836

Review 3.  Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms.

Authors:  Shaun P Jackson; Roxane Darbousset; Simone M Schoenwaelder
Journal:  Blood       Date:  2019-01-14       Impact factor: 22.113

Review 4.  Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke.

Authors:  Charles C Esenwa; Mitchell S Elkind
Journal:  Nat Rev Neurol       Date:  2016-09-12       Impact factor: 42.937

5.  Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease.

Authors:  Chris Tikellis; M C Thomas
Journal:  Int J Pept       Date:  2012-03-20

6.  Endothelial cell infection and endotheliitis in COVID-19.

Authors:  Zsuzsanna Varga; Andreas J Flammer; Peter Steiger; Martina Haberecker; Rea Andermatt; Annelies S Zinkernagel; Mandeep R Mehra; Reto A Schuepbach; Frank Ruschitzka; Holger Moch
Journal:  Lancet       Date:  2020-04-21       Impact factor: 79.321

7.  The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities.

Authors:  Louis Maximilian Buja; Dwayne A Wolf; Bihong Zhao; Bindu Akkanti; Michelle McDonald; Laura Lelenwa; Noah Reilly; Giulia Ottaviani; M Tarek Elghetany; Daniel Ocazionez Trujillo; Gabriel M Aisenberg; Mohammad Madjid; Biswajit Kar
Journal:  Cardiovasc Pathol       Date:  2020-05-07       Impact factor: 2.185

8.  Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.

Authors:  Luca Carsana; Aurelio Sonzogni; Ahmed Nasr; Roberta Simona Rossi; Alessandro Pellegrinelli; Pietro Zerbi; Roberto Rech; Riccardo Colombo; Spinello Antinori; Mario Corbellino; Massimo Galli; Emanuele Catena; Antonella Tosoni; Andrea Gianatti; Manuela Nebuloni
Journal:  Lancet Infect Dis       Date:  2020-06-08       Impact factor: 25.071

9.  Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young.

Authors:  Thomas J Oxley; J Mocco; Shahram Majidi; Christopher P Kellner; Hazem Shoirah; I Paul Singh; Reade A De Leacy; Tomoyoshi Shigematsu; Travis R Ladner; Kurt A Yaeger; Maryna Skliut; Jesse Weinberger; Neha S Dangayach; Joshua B Bederson; Stanley Tuhrim; Johanna T Fifi
Journal:  N Engl J Med       Date:  2020-04-28       Impact factor: 91.245

10.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.

Authors:  Markus Hoffmann; Hannah Kleine-Weber; Simon Schroeder; Nadine Krüger; Tanja Herrler; Sandra Erichsen; Tobias S Schiergens; Georg Herrler; Nai-Huei Wu; Andreas Nitsche; Marcel A Müller; Christian Drosten; Stefan Pöhlmann
Journal:  Cell       Date:  2020-03-05       Impact factor: 41.582
View more
  8 in total

Review 1.  Carotid Enadrterectomy for Thrombosis of the Internal Carotid Artery in Patients With COVID-19.

Authors:  A N Kazantsev; M R Karkayeva; A P Tritenko; A V Korotkikh; A S Zharova; K P Chernykh; G Sh Bagdavadze; R Yu Lider; Ye G Kazantseva; K L Zakharova; D V Shmatov; V N Kravchuk; K S Peshekhonov; N E Zarkua; V A Lutsenko; R V Sultanov; S V Artyukhov; E U Kharchilava; K N Solotenkova; A B Zakeryayev
Journal:  Curr Probl Cardiol       Date:  2022-05-13       Impact factor: 16.464

Review 2.  COVID-19 and cerebrovascular diseases: a comprehensive overview.

Authors:  Georgios Tsivgoulis; Lina Palaiodimou; Ramin Zand; Vasileios Arsenios Lioutas; Christos Krogias; Aristeidis H Katsanos; Ashkan Shoamanesh; Vijay K Sharma; Shima Shahjouei; Claudio Baracchini; Charalambos Vlachopoulos; Rossetos Gournellis; Petros P Sfikakis; Else Charlotte Sandset; Andrei V Alexandrov; Sotirios Tsiodras
Journal:  Ther Adv Neurol Disord       Date:  2020-12-08       Impact factor: 6.570

3.  Risk, Clinical Course, and Outcome of Ischemic Stroke in Patients Hospitalized With COVID-19: A Multicenter Cohort Study.

Authors:  Wouter M Sluis; Marijke Linschoten; Julie E Buijs; J Matthijs Biesbroek; Heleen M den Hertog; Tessa Ribbers; Dennis J Nieuwkamp; Reinier C van Houwelingen; Andreas Dias; Ingeborg W M van Uden; Joost P Kerklaan; H Paul Bienfait; Sarah E Vermeer; Sonja W de Jong; Mariam Ali; Marieke J H Wermer; Marieke T de Graaf; Paul J A M Brouwers; Folkert W Asselbergs; L Jaap Kappelle; H Bart van der Worp; Annemijn M Algra
Journal:  Stroke       Date:  2021-11-04       Impact factor: 7.914

Review 4.  Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?

Authors:  Marios Sagris; Panagiotis Theofilis; Alexios S Antonopoulos; Evangelos Oikonomou; Kostas Tsioufis; Dimitris Tousoulis
Journal:  Biomedicines       Date:  2022-01-24

Review 5.  Neurological consequences of COVID-19.

Authors:  Waldemar Brola; Maciej Wilski
Journal:  Pharmacol Rep       Date:  2022-09-30       Impact factor: 3.919

6.  Carotid intima-media thickness and flow-mediated dilation do not predict acute in-hospital outcomes in patients hospitalized with COVID-19.

Authors:  Michelle Cristina-Oliveira; Kamila Meireles; Saulo Gil; Fábio Cavalcante Assis; João Carlos Geber-Júnior; Samuel Katsuyuki Shinjo; Heraldo Possolo de Souza; Alfredo Nicodemos Cruz Santana; Paul A Swinton; Luciano F Drager; Bruno Gualano; Hamilton Roschel; Tiago Peçanha
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-03-25       Impact factor: 4.733

Review 7.  Symptomatic Common Carotid Free-Floating Thrombus in a COVID-19 Patient, Case Report and Literature Review.

Authors:  Susana Cancer-Perez; Jesús Alfayate-García; Sandra Vicente-Jiménez; Manuel Ruiz-Muñoz; Fanny Patricia Dhimes-Tejada; Miguel Gutiérrez-Baz; Fernando Criado-Galan; Miryam Perera-Sabio; Luis de Benito-Fernández
Journal:  Ann Vasc Surg       Date:  2021-03-06       Impact factor: 1.466

8.  Multimodal imaging features of transient perivascular inflammation of the carotid artery (TIPIC) syndrome in a patient with Covid-19.

Authors:  Evangelis Venetis; Deborah Konopnicki; Patrice Jissendi Tchofo
Journal:  Radiol Case Rep       Date:  2022-01-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.